JAKi Salvage Therapy Followed by Curative Cord Blood Transplantation in a XIAP-Deficient Infant with Relapsing HLH

J Clin Immunol. 2023 Aug;43(6):1178-1181. doi: 10.1007/s10875-023-01522-7. Epub 2023 May 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cord Blood Stem Cell Transplantation*
  • Graft vs Host Disease*
  • Humans
  • Infant
  • Lymphohistiocytosis, Hemophagocytic* / diagnosis
  • Lymphohistiocytosis, Hemophagocytic* / genetics
  • Lymphohistiocytosis, Hemophagocytic* / therapy
  • Recurrence
  • Salvage Therapy
  • X-Linked Inhibitor of Apoptosis Protein* / genetics

Substances

  • X-Linked Inhibitor of Apoptosis Protein
  • XIAP protein, human